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Abstract
Obesity causes lipid accumulation in the heart and may lead to lipotoxic heart disease. Traditionally, the size of the cardiac
triglyceride pool is thought to reflect the balance between uptake and b-oxidation of fatty acids. However, triglycerides can
also be exported from cardiomyocytes via secretion of apolipoproteinB-containing (apoB) lipoproteins. Lipoprotein
formation depends on expression of microsomal triglyceride transfer protein (MTP); the mouse expresses two isoforms of
MTP, A and B. Since many aspects of the link between obesity-induced cardiac disease and cardiac lipid metabolism remain
unknown, we investigated how cardiac lipoprotein synthesis affects cardiac expression of triglyceride metabolism-
controlling genes, insulin sensitivity, and function in obese mice. Heart-specific ablation of MTP-A in mice using Cre-loxP
technology impaired upregulation of MTP expression in response to increased fatty acid availability during fasting and fat
feeding. This resulted in cardiac triglyceride accumulation but unaffected cardiac insulin-stimulated glucose uptake. Long-
term fat-feeding of male C57Bl/6 mice increased cardiac triglycerides, induced cardiac expression of triglyceride
metabolism-controlling genes and attenuated heart function. Abolishing cardiac triglyceride accumulation in fat-fed mice
by overexpression of an apoB transgene in the heart prevented the induction of triglyceride metabolism-controlling genes
and improved heart function. The results suggest that in obesity, the physiological increase of cardiac MTP expression
serves to attenuate cardiac triglyceride accumulation albeit without major effects on cardiac insulin sensitivity. Nevertheless,
the data suggest that genetically increased lipoprotein secretion prevents development of obesity-induced lipotoxic heart
disease.
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Introduction
Obesity is associated with increased risk of cardiac failure and
death [1,2]. As a consequence of the increasing prevalence of
obesity it is pertinent to improve understanding of the metabolic
alterations causing cardiac dysfunction in overweight individuals.
Obesity instigates intracellular accumulation of triglycerides in
cardiac myocytes [3–5]. Lipid accumulation and altered metab-
olism of free fatty acids are associated with development of
myocardial contractile dysfunction and may lead to cardiac
myocyte apoptosis [5–8]. Although, the mechanisms involved in
development of obesity-associated heart disease remain to be fully
clarified, they appear to be independent from those leading to
ischemia-induced heart dysfunction. Consequently, lipotoxic heart
disease has been proposed as a distinct form of cardiomyopathy
associated with obesity and type 2 diabetes [9–11].
Lipid accumulation in the heart results from an imbalance
between uptake and utilization of free fatty acids. Under normal
conditions, ,70% of the energy production in the heart is derived
from fatty acids [10]. Heart failure is accompanied by myocyte
lipid accumulation, which has been explained by a switch in
substrate utilization from fatty acids to glucose [12] leading to
storage of the excess fatty acids as triglycerides. However, obesity is
accompanied by both increased utilization of fatty acids for energy
production and lipid accumulation both in humans and mice
[4,5,13]. This apparent paradox may be explained by increased
delivery of fatty acids to the heart in obesity [14,15]. Increased
plasma free fatty acids promote increased cardiac uptake reflecting
the concentration gradient between plasma and the intracellular
milieu in the cardiac myocytes [16,17]. Moreover, obesity and
cardiac lipid accumulation has been associated with increased
heart expression of genes that stimulate local production (i.e.
lipoprotein lipase (LPL)) and transport protein mediated uptake
(i.e., fatty acid translocase (FAT/CD36), fatty acid transporter
protein 1 (FATP1) and fatty acid transporter protein 4 (FATP4)) of
free fatty acids [5]. The regulatory role of cardiac free fatty acid
uptake in lipotoxic heart disease is underscored by seminal studies
showing that overexpression of LPL and FATP1 causes cardiac
triglyceride accumulation and cardiac dysfunction in lean mice
[18,19]. In the obese heart, the increased availability of free fatty
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5300acids is also associated with upregulation of genes involved with
fatty acid metabolization and increased utilization of fat for energy
production [8].
Divergence of the net metabolic flux of fatty acids from the
oxidative pathway leads to myocardial triglyceride accumulation
and development of lipotoxic heart disease in mouse models that
overexpress either PPARa or long-chain acyl-CoA synthetase
(ACSL) [20,21], or are long-chain acyl-CoA dehydrogenase-
deficient (LCAD) [22]. The obese rat heart displays increased
expression of uncoupling protein 3 (UCP3) shunting free fatty
acids out of the mitochondria and increasing cytosolic fatty acid
levels [23]. The excess availability of fatty acids that are not used
for energy production leads to accumulation of intracellular
triglycerides. The turnover time of triglycerides in the heart is
extremely rapid (,5 hours) compared to adipose tissue (200–270
days) [10,24,25]. This implies that cardiac triglyceride accumula-
tion is not inert but rather is associated with markedly increased
intracellular fluxes of free fatty acids.
The human heart expresses the two genes that are mandatory
for formation of apoB-containing lipoproteins, i.e. the microsomal
triglyceride transfer protein (MTP) gene and the apoB gene [26].
MTP is an intracellular protein located in the endoplasmatic
reticulum, which transfers neutral lipids onto the apoB polypeptide
and participates in the subsequent lipidation of the nascent
lipoproteins [27]. Two recent reports independently demonstrated
that there are two isoforms of the MTP gene in the mouse MTP-A
and MTP-B (also named MTP and MTPv1) [28,29]. The MTP-B
variant has a unique exon 1 located 2.7 kb 59 to the canonical
exon 1 resulting in translation of a different signal peptide and
addition of three amino acids at the NH2-terminus of the mature
MTP protein [28,29]. The physiological role of apoB is to package
and secrete lipids in the form of lipoproteins. Indeed, cardiac
myocytes secrete apoB-containing lipoproteins [30] and cardiac
triglyceride accumulation is attenuated in apoB-overexpressing
transgenic mice with streptozotocin-induced type 1 diabetes [31],
lipoprotein lipase overexpressing mice [32], and LCAD-deficient
mice [33]. These findings indicate that export of triglycerides in
the form of lipoproteins can reduce pathological triglyceride
accumulation. Therefore, export of triglycerides in the form of
lipoproteins may represent a novel pathway in cardiac lipid
metabolism that deserves further exploration.
We have utilized mice overexpressing a full length human apoB
transgene and mice lacking cardiac expression of MTP-A to
explore the role of cardiac lipoprotein formation on lipid
metabolism and heart function in mice with diet-induced obesity.
The data suggest that local lipoprotein secretion is integrated with
cardiac lipid metabolism and protects against obesity-induced
lipotoxic heart disease.
Results
Induction of MTP-B in MTP-A-deficient mouse hearts
Ob/ob mice have increased cardiac triglyceride stores, which are
associated with increased total MTP mRNA expression and MTP
activity in the myocardium [5]. This may reflect that increased
lipoprotein formation is a compensatory mechanism dampening
cardiac lipid accumulation in the setting of excess supplies of fatty
acids.
Real-time PCR studies with MTP-A and MTP-B specific assays
showed that the expression of both isoforms is increased in mice
with diet-induced obesity after fat-feeding (60% energy from fat)
for ,1 yr (Fig. S1). To explore the importance of the two MTP
isoforms in the heart of obese mice, we bred mice with loxP sites
flanking exon 1 of the MTP-A gene (Mttp
flox/flox) [34] with
transgenic mice that express Cre-recombinase in the heart and
skeletal muscle, but not in liver (Mck-Cre
+/o mice) (Fig. 1A).
Predictably, deletion of exon-1 of MTP-A should not abolish
MTP-B expression since exon 1 of the MTP-B isoform is located
,2.7 kb upstream of exon 1 of MTP-A. Chow-fed (12% energy
from fat) Mttp
flox/floxMck-Cre
+/o mice had a .95% reduction of
MTP-A mRNA in the heart and unchanged MTP-A mRNA
expression in the liver as compared with Mttp
flox/flox mice
indicating that ablation of MTP-A in cardiac myocytes was highly
effective and tissue specific (Fig. 1B). Nevertheless, the cardiac total
MTP (MTP-A+MTP-B) mRNA expression was increased 1.4 fold
in Mttp
flox/floxMck-Cre
+/o mice compared with Mttp
flox/flox
littermates (Fig. 1C). This increase was attributable to a ,3.6
fold elevation (P=0.0006) of the MTP-B mRNA expression
(Fig. 1D) and may reflect increased transcription of MTP-B from
the Cre-loxP-modified MTP gene locus.
The ability of the MTP-B isoform to mediate triglyceride transfer
was evaluated by incubating cardiac microsomal protein fractions
from Mttp
flox/floxMck-Cre
+/o mice with
14C-trioleate-labeled lipid
vesicles.CardiacMTPactivitywassimilarinMttp
flox/floxMck-Cre
+/o
mice and with Mttp
flox/flox littermates (Fig. 1E). Moreover, cardiac
triglyceride and cholesterol concentrations were similar in chow-fed,
non-fasted Mttp
flox/floxMck-Cre
+/o mice and Mttp
flox/flox littermates
(Fig.1Fanddatanotshown).Theseresultsindicatethatupregulation
ofMTP-B can compensate for the lossofMTP-A intheheart of lean
chow-fed mice.
Effect of MTP-A deficiency on lipid accumulation and
expression of lipid metabolizing genes in obese mouse
heart
Previous studies suggest that mice with heart-specific MTP-A
deficiency accumulate excess cardiac triglycerides after fasting [33].
Fastingincreasesthedeliveryoffreefattyacidstotheheartandcauses
cardiactriglycerideaccumulation[16].Thus,itisconceivablethatthe
effect of MTP-A deficiency only becomes evident in the setting of
surplussuppliesoffattyacidsandassuchcouldbeimportantinobese
mice. We examined this possibility by comparing hearts from
Mttp
flox/floxMck-Cre
+/o mice and Mttp
flox/flox littermates that had
been fed a chow diet and fasted for 18 hours or had been fed a fat-
enriched diet for 3 months. After fasting or fat-feeding the cardiac
triglyceride content was higher in Mttp
flox/floxMck-Cre
+/o mice
compared with Mttp
flox/flox littermates (P,0.05) (Fig. 2A). Notably,
after fasting the cardiac MTP activity was increased in Mttp
flox/flox
mice (P=0.009) but not in Mttp
flox/floxMck-Cre
+/o mice (Fig. 2B).
Moreover,afterfatfeedingMTP-AandMTP-Bexpressionincreased
inMttp
flox/floxcontrolmice(Fig.2C)whereasMTP-Bexpressionwas
unaffected in Mttp
flox/floxMck-Cre
+/o mice (Fig. 2D). The present
data thus imply that the excess cardiac triglyceride accumulation in
Mttp
flox/floxMck-Cre
+/o mice occurs due to defect transcriptional
activation of the ablatedMTP gene locus afterfasting- or fat-feeding.
Moreover, the results thus support the notion that a compensatory
increase in cardiac MTP expression protects against cardiac
triglyceride accumulation in the obese mouse heart.
Diet-induced obesity has been associated with impaired insulin-
stimulated glucose uptake in skeletal muscle [35] and altered lipid
metabolism in cardiac muscle [20]. There was no excess
triglyceride accumulation in the hearts of Mttp
flox/flox control
mice after 3 months of fat-feeding (compare Fig. 1F and Fig 2A)
which is in accord with previous findings by Somoza et al [13].
Nevertheless, insulin-stimulated glucose uptake was markedly
reduced in the heart (as well as in skeletal muscle and adipose
tissue) when insulin was injected intravenously together with 2-
deoxy-[
3H]glucose 25 minutes prior to removal of the mouse heart
(Fig. 3A–C). The decrease in cardiac insulin-sensitivity occurred
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(PFK) mRNA expression (involved in uptake and oxidation of
glucose) (Fig 3D). Fat-feeding of the Mttp
flox/flox control mice for 3
months also caused significant increases in the expression of
several lipid metabolizing genes which mediate free fatty acid
uptake, i.e. FAT/CD36, FATP1, FATP4, intracellular transport,
Figure 1. Effect of heart-specific MTP-A-deficiency in chow-fed mice. Mttp
flox/flox mice were bred with Mck-Cre
+/o mice to generate mice
with heart-specific MTP-A-deficiency. A) Cre mRNA expression in liver (n=4) and heart (n=4) of Mttp
flox/floxMck-Cre
+/o mice, B) MTP-A mRNA
expression in the liver (n=4 in each group) and heart (n=8 in each group) of Mttp
flox/flox and Mttp
flox/floxMck-Cre
+/o mice, C) Total MTP mRNA
expression in the heart of Mttp
flox/flox (n=8) and Mttp
flox/floxMck-Cre
+/o mice (n=8), D) Cardiac MTP-B mRNA expression in Mttp
flox/flox (n=8) and
Mttp
flox/floxMck-Cre
+/o mice (n=8), E) Cardiac MTP activity Mttp
flox/flox (n=6) and Mttp
flox/floxMck-Cre
+/o mice (n=6), F) Cardiac triglycerides in
Mttp
flox/flox (n=8) and Mttp
flox/floxMck-Cre
+/o mice (n=8). Open bars: Mttp
flox/flox mice and closed bars: Mttp
flox/floxMck-Cre
+/o mice. Values are
mean6SEM. The p values for two-group comparisons are: ** P,0.01; *** P,0.005 compared to chow-fed controls.
doi:10.1371/journal.pone.0005300.g001
Figure 2. Effect of heart-specific MTP-A deficiency on cardiac lipid accumulation and MTP activity in fasted mice and fat-fed obese
mice. A) cardiac triglycerides in mice that were fasted for 18 hours and mice that were fat-fed for three months (n=7–9 in each group). *P,0.05
compared to Mttp
flox/flox mice. B) MTP activity in fasted versus chow-fed mice (n=6 in each group). **P,0.01 compared to fed mice, { P,0.01 fasted
Mttp
flox/flox compared to fasted Mttp
flox/floxMck-Cre
+/o mice A+B) Open bars: Mttp
flox/flox mice and closed bars: Mttp
flox/floxMck-Cre
+/o mice. C) MTP-A
and MTP-B mRNA expression in fat-fed (closed bars) versus chow-fed (open bars) Mttp
flox/flox mice (n=7 in each group). **P,0.01 and ***P,0.005
compared to chow-fed Mttp
flox/flox mice. D) MTP-A and MTP-B mRNA expression in fat-fed (closed bars) versus chow-fed (open bars) Mttp
flox/floxMck-
Cre
+/o mice (n=7 in each group). Values are mean6SEM.
doi:10.1371/journal.pone.0005300.g002
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group from acyl-CoA in the cytosol, i.e. cytosolic acyl-CoA
thioesterase 1 (CTE1), mitochondrial uptake of fatty acids, i.e.
carnitine palmitoyltransferase 1b (CPT1b), and shunting of fatty
acids out the mitochondria, i.e. UCP3 (Fig. 3D). This suggests that
diet-induced obesity causes alterations in cardiac glucose and lipid
metabolism that precedes lipid accumulation in myocytes.
There was no difference in cardiac insulin-stimulated glucose
uptake between Mttp
flox/floxMck-Cre
+/o and Mttp
flox/flox control
mice (Fig 3A). However, the mRNA expression of diacylglycerol
acyltransferase (DGAT) and PPARa was reduced in fat-fed
Mttp
flox/floxMck-Cre
+/o mice compared with the fat-fed
Mttp
flox/flox mice (Fig. 3D), supporting the notion that rates of
lipoprotein secretion may modulate cardiac triglyceride
homeostasis in the setting of diet-induced obesity.
Cardiac triglyceride accumulation in fat-fed obese mice is
prevented by overexpression of human apoB in the heart
Prolonged excess caloric intake increases cardiac triglyceride
stores in mice [5]. We fed the fat-enriched diet to human apoB-
transgenic male mice and litter-mate C57Bl/6 controls for ,1
year to explore the impact of increased rates of cardiac lipoprotein
formation in the setting of obesity and increased cardiac
triglyceride stores. Fat-feeding induced equal increases in body
weight, plasma insulin, leptin, and glucose in male C57Bl/6 mice
and their apoB-transgenic littermates (Fig. S2A–F). Fasting plasma
concentrations of free fatty acids after 9 months of fat-feeding were
increased in to a similar extent in fat-fed C57Bl/6 mice and
human apoB-transgenic littermates (0.8060.03 mmol/L and
0.8760.05 mmol/L) compared with chow-fed control mice
(0.6660.07 mmol/L and 0.3460.01 mmol/L) (P,0.0001). After
12 months of fat-feeding, the heart triglyceride content was 110%
increased in obese C57Bl/6 mice compared with lean C57Bl/6
mice (Fig. 4A). The obesity-induced increase in cardiac triglycer-
ides was abolished in human apoB-transgenic mice (Fig. 4A).
Neither cardiac cholesterol (data not shown) nor ceramide levels
were affected by fat-feeding or overexpression of the human apoB
transgene. The cardiac ceramide concentration was 2061 nmol/
mg wet weight (ww) in fat-fed versus 1861 nmol/mg ww in chow-
fed C57Bl/6 mice (P=0.15), and 2162 nmol/mg ww in fat-fed
versus 2362 nmol/mg ww in chow-fed apoB-transgenic mice
(P=0.61). These results suggest that increased lipoprotein
Figure 3. Effect of heart-specific MTP-A deficiency on insulin-stimulated glucose uptake and expression of lipid metabolizing genes
in obese mouse heart. The effect of heart-specific MTP-A deletion on A) insulin-stimulated glucose uptake in cardiac ventricles, B) skeletal muscle,
and C) epididymal fat was determined after 3 months of fat-feeding. D) Cardiac mRNA expression was quantified with real-time PCR in fat-fed male
Mttp
flox/flox mice, Mttp
flox/floxMck-Cre
+/o mice and their lean controls. Values are after 3 months of diet. Open bars: chow-fed Mttp
flox/flox mice (n=7–8),
closed bars: fat-fed Mttp
flox/flox mice (n=7–8), hatched bars: chow-fed Mttp
flox/floxMck-Cre
+/o mice (n=7–8), squared bars: fat-fed Mttp
flox/floxMck-Cre
+/o
mice (n=7). Values are mean6SEM. The p values for two-group comparisons are: * P,0.05, ** P,0.01; *** P,0.005 compared to chow-fed controls; {
P,0.01 compared to fat-fed Mttp
flox/floxMck-Cre
+/o mice.
doi:10.1371/journal.pone.0005300.g003
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without affecting cholesterol or ceramide stores in hearts of long-
term fat-fed obese mice.
Overexpression of human apoB in the heart affects
expression of genes involved in cardiac metabolism of
free fatty acids
To judge whether increased lipoprotein formation affect
metabolism of free fatty acids in hearts with excess lipid
accumulation, we quantified the expression of selected genes
controlling key steps in cardiac fatty acid metabolism. The mRNA
levels of FAT/CD36, FATP1 and FATP4, CTE1, ACSL1 which
couples the CoA group to fatty acids in the cytosol, CPT1b and
LCAD which is involved in b-oxidation of fatty acids, were all
increased in hearts from 1-yr fat-fed C57Bl/6 mice compared to
chow-fed mice respectively (Fig. 4B). Notably, the magnitudes of
the changes in gene expression were much more pronounced after
fat-feeding for 1 year than after 3 months (compare Fig 3D and
4B). In contrast to the findings in C57Bl/6 mice, the cardiac
expression of genes associated with fatty acid metabolizing showed
less or no increase in fat-fed human apoB-transgenic mice (Fig. 4B).
Thus, the expression levels of FAT/CD36, FATP1, FATP4,
CTE1, and ACLS1 were significantly lower in hearts from fat-fed
human apoB-transgenic than in the fat-fed C57Bl/6 littermates
(Fig. 4B). These results suggest that increased lipoprotein
formation attenuates changes in gene expression that increase
uptake and metabolization of free fatty acids in the hearts of long-
term fat-fed mice.
In accordance with previous results in obese ob/ob mice [5] and
fa/fa Zucker rats [36] GLUT4 as well as PFK displayed increased
mRNA expression in the fat-fed C57Bl/6 mouse hearts. In hearts
Figure 4. Overexpression of human apoB in the heart affects cardiac triglyceride levels as well as expression of genes involved in
cardiac stress and metabolism of free fatty acids in fat-fed C57Bl/6 mice. The effect of cardiac overexpression of a human apoB-transgene in
obese mice on A) cardiac triglycerides were determined using TLC, B) cardiac mRNA expression of lipid metabolising genes and C) cardiac mRNA
expression of stress-related genes was quantified with real-time PCR in male fat-fed C57Bl/6 (n=11) and C57Bl/6-apoB-Tg mice (n=9) and their lean
controls (n=6). Values are after 12 months of diet. Open bars: chow-fed C57Bl/6 mice, closed bars: fat-fed C57Bl/6 mice, hatched bars: chow-fed C57Bl/
6-apoB-Tg mice, squared bars: fat-fed C57Bl/6-apoB-Tg mice. Values are mean6SEM. The p values for two-group comparisons are: * P,0.05, **
P,0.01; *** P,0.005 compared to chow-fed controls; { P,0.05 Fat-fed C57Bl/6 compared to fat-fed C57Bl/6-apoB-Tg.
doi:10.1371/journal.pone.0005300.g004
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not identify this difference in GLUT4 and PFK mRNA expression
(Fig. 4B). This suggests that normalization of cardiac lipid stores
not only affects lipid metabolism but also prevents changes in
expression of essential genes governing glucose metabolism.
Overexpression of human apoB in the heart attenuates
deterioration of cardiac function in fat-fed obese mice
Recent data demonstrated that fat-feeding of C57Bl/6 male
mice results in deterioration of heart function [35]. This may result
from cardiac lipid accumulation and increased uptake and
metabolization of free fatty acids [37]. We therefore hypothesized
that mitigated cardiac triglyceride accumulation and dampened
uptake and metabolization of fatty acids in human apoB
transgenic mice might alleviate adverse effects of fat-feeding on
heart function. To test this idea, we examined in vivo heart function
in human apoB-transgenic male mice and littermate C57Bl/6
controls that had been fat- or chow-fed for 11 months. Ejection
fraction (EF) and the load-independent index, preload recruitable
stroke work (PRSW) were decreased in fat-fed C57Bl/6 mice
compared with chow-fed C57Bl/6 mice (Fig. 5A and 5B). In
addition, the heart rate was reduced in the fat-fed versus chow-fed
C57Bl/6 mice (Supplementary Table S1). This was in contrast to
human apoB transgenic mice where neither of these variables was
significantly altered in fat-fed compared to chow-fed mice (Fig. 5A
and 5B and Supplementary Table S1). We did not observe any
effects of fat-feeding or apoB overexpression on electrocardio-
graphic recordings (data not shown). The results are compatible
with the idea that increased lipoprotein formation in cardiac
myocytes attenuates development of cardiac dysfunction in fat-fed
obese mice.
Obesity and type 2 diabetes increase intracellular stress
promoting apoptosis and insulin resistance [38,39]. Increased
expression of uncoupling protein 2 (UCP2) and UCP3 (directing
fatty acids fluxes away from oxidative pathways) and of the pro-
apoptotic growth arrest and DNA-damage-inducible gene 34
(GADD34) mRNA are markers of myocardial stress. For all three
genes, the expression was increased in the heart of long-term fat-
fed versus chow-fed C57Bl/6 mice, but was less or unaffected in
fat-fed versus chow-fed human apoB-transgenic mice (Fig. 4C).
GADD34 expression can be induced by a number of pathways
including stress in the endoplasmatic reticulum [40]. However,
cardiac mRNA expression of two markers of ER stress
(immunoglobulin heavy chain-binding protein (BiP) and C/EBP-
homologous protein (CHOP)) was not affected by fat feeding (data
not shown).
Discussion
The present data suggest that cardiac secretion of apoB-
containing lipoproteins plays an integrated role in cardiac fatty
acid metabolism and affects myocardial function in obese mice.
Failure to upregulate MTP activity in fasted and short-term fat-fed
mice with targeted MTP-A expression increased cardiac triglyc-
eride stores. Overexpression of apoB attenuated triglyceride
accumulation in the heart of long-term fat-fed obese mice. Thus,
genes controlling lipoprotein synthesis, in addition to genes
controlling rates of uptake and utilization of fatty acids in energy
production, are significant determinants of cardiac triglyceride
homeostasis in the obese heart.
Expression of MTP is mandatory for lipoprotein formation [41].
Both the canonical MTP-A isoform and the recently discovered
MTP-B isoform are expressed in the murine heart. The expression
of both MTP isoforms is increased in the heart of fat-fed obese
mice suggesting that MTP is integrated in cardiac lipid
metabolism. Complete MTP deficiency is embryonically lethal in
mice [42]. We used mice with heart-specific deficiency of the
MTP-A gene to study the role of MTP in the heart. Based on the
Figure 5. Overexpression of human apoB in the heart
attenuates deterioration of cardiac function in fat-fed obese
mice. Heart function was determined with a conductance catheter
placed in the left cardiac ventricle A) EF, ejection fraction, B) PRSW,
preload recruitable stroke work. Open bars: chow-fed C57Bl/6 mice
(n=7), closed bars: fat-fed C57Bl/6 mice (n=7), hatched bars: chow-fed
C57Bl/6-apoB-Tg mice (n=11), squared bars: fat-fed C57Bl/6-apoB-Tg
mice (n=7). Values are mean6SEM after 11 months on the diets. The p
values for two-group comparisons are: * P,0.05, ** P#0.01.
doi:10.1371/journal.pone.0005300.g005
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wild-type and MTP-A deficient mice, it can be estimated that
,35% of the total amount of MTP mRNA represents the MTP-B
transcript and ,65% represents the MTP-A transcript in the
mouse heart. The MTP-B isoform likely is functionally active in
cardiac lipoprotein formation since the MTP-A deficient mouse
hearts expressed the same MTP activity as control hearts and did
not accumulate triglycerides when the mice were on a normal
chow. Notably, direct evidence of MTP-B mediated lipoprotein
formation in the heart was not provided by the present studies.
Nevertheless, it is interesting that mice with heart-specific MTP-A
deficiency, in contrast to wild type mice, could not upregulate
MTP expression and accumulated excess triglycerides in the heart
in response to fasting or 3 months of fat-feeding. This suggests that
upregulation of cardiac MTP expression serves to protect against
myocardial lipid accumulation when the supply of fatty acids
exceeds the need for energy production. A promoter polymor-
phism in the MTP gene is associated with decreased MTP gene
expression and excess cardiovascular mortality in patients with
ischemic heart disease [43]. The present data thus warrants further
studies to determine whether MTP promoter polymorphisms
could also affect the risk of obesity-induced heart disease.
Triglyceride accumulation in skeletal muscle is associated with
insulin resistance [44]. Recent studies, however, suggest that
increased muscle uptake and metabolism of free fatty acids rather
than fat accumulation in itself causes the insulin resistance in obesity
[45,46]. The present findings in the mouse heart are in accordance
with this idea. Thus, the heart was insulin resistant in obese mice
after 12 weeks of fat feeding. At this time point there was increased
cardiac expression of lipid metabolizing genes but no excess cardiac
triglyceride accumulation (cardiac triglycerides in Mttp
flox/flox
control mice were actually lower in the fat-fed group than in the
chow-fed group, as seen in Fig. 1F and Fig. 2A). Moreover, cardiac
insulinsensitivitywasunaffectedbythe increased cardiactriglyceride
stores in Mttp
flox/floxMck-Cre
+/o mice.
Several studies demonstrates that obesity-induced changes in
cardiac energy metabolism involve increased uptake and utiliza-
tion of free fatty acids that ultimatively lead to cardiac lipid
accumulation [5,47,48]. Altered fatty acid metabolism leads to
decreased metabolic flexibility which is detrimental to the function
of the myocardium, e.g. due to increased formation of reactive
oxygen species [49–51]. Interestingly, overexpression of apoB in
the heart of long-term-fat-fed obese mice not only prevented
cardiac triglyceride accumulation but also reduced the effect of fat-
feeding and obesity on genes controlling fatty acid metabolism in
the heart. The reduction of cardiac triglycerides in the fat-fed
apoB transgenic mice was associated with partial normalization of
the expression of genes that are key regulators of cardiac fatty acid
uptake, cytosolic release of free fatty acids from acyl-CoA, and
uncoupling of fatty acid b-oxidation in mitochondria. Increased
expression of FAT/CD36, FATP1, UCP2 and UCP3 have all
been implicated in development of lipotoxic heart disease
[20,52,53]. Thus, the results are compatible with the idea that
normalization of cardiac lipids via increased export in lipoproteins
leads to decreased uptake and metabolism of fatty acids and
confers at least partial resistance to the detrimental effect of obesity
on myocardial function. Notably, normalization of triglyceride
store also reduced the expression of genes involved with glucose
metabolism and the GADD34 marker of cardiac stress. Thus, the
data suggest that reduction of cardiac triglyceride stores have
effects on cardiac energy utilization that exceeds lipid metabolism
and, as such, is a key controlling factor in precipitation of lipotoxic
heart disease in obesity. It should be noted, however, that this
conclusion is based on mRNA expression data and further studies
are needed to explore the impact of lipoprotein formation on
cardiac energy metabolism in vivo.
In conclusion, the present results support that cardiac
lipoprotein synthesis and secretion is important for controlling
the triglyceride storage in the heart of mice when fatty acid
supplies are increased, such as in obesity. In addition, the export of
triglycerides in lipoproteins appears to reduce the effect of obesity
on the otherwise perturbed expression profile of free fatty acid
metabolizing genes and protect against adverse effects of obesity
on myocardial function.
Materials and Methods
Mice
Mice with heart-specific MTP-A deficiency were obtained by
breeding MTP loxp mice (stock no: 003902, Jackson Laboratories,
USA) with Mck-Cre mice [54] to obtain Mttp
flox/floxMck-Cre
+/o
mice and Mttp
flox/flox littermate controls. For the study of cardiac
MTP-activity and response to fasting the mice were kept on the
standard chow diet. For the study of obesity-associated effects on the
heart, 7-week-old micewere randomly assigned to either the high-fat
diet or the standard chow diet for 12 weeks. At the end of the fat-
feeding period the body weight was 43.461.7 g (n=7) in fat-fed
Mttp
flox/flox, 45.561.8 g (n=8) in Mttp
flox/floxMck-Cre
+/o,
31.260.6 g (n=8) in chow-fed Mttp
flox/flox, and 30.661.0 g (n=8)
in chow fed Mttp
flox/floxMck-Cre
+/o mice. Seven-week-old male
C57Bl/6 and human apoB-transgenic mice (B6.SJL-Tg(A-
POB)1102Sgy-mice backcrossed to the C57Bl/6 background for
.20 generations) littermates were randomized to a high-fat diet with
60% fat (D12492,Research Diets) or a standard chow diet with 12%
fat (Altromin 1314, Brogaarden, Denmark). Heart function was
studied after 45 weeks on the diet whereas cardiac gene expression
and lipid accumulation was studied in separate mice after 52 weeks
on the diet. The mice fed for 52 weeks were also used as a part of
another study of atherosclerosis [55]. The animals were housed
undertemperature-controlledconditionswith free accessto foodand
water. The studies were approved by the Danish Animal
Experiments Inspectorate (Dyreforsoegstilsynet).
Blood and tissue samples
Blood were drawn in pre-cooled tubes containing Na2-EDTA
and centrifuged at 4000?g for 10 minutes at 4uC. The hearts were
carefully cleaned from pericardial fat and atrial tissue before snap
frozen in liquid nitrogen. Tissue and plasma samples were stored
at 280uC until use.
Plasma biochemistry
Plasma glucose in tail blood was determined with a Medisense
PCx glucose meter (Abbott Laboratories A/S, Gentofte, Den-
mark). Plasma free fatty acids concentrations were determined
with an enzymatic kit (Wako NEFA C kit, TriChem Aps,
Frederikssund, Denmark). Sandwich elisa assays were used to
measure plasma insulin and leptin (catalogue no. EIA-3440, DRG,
Germany, and catalogue no. RD291001200R, BioVendor,
Heidelberg, Germany, respectively).
Cardiac triglycerides
Lipids were extracted, re-dissolved in toluene, and separated
with TLC prior to quantification as previously described [56].
Cardiac ceramides
Cardiac ceramides were purified from lipid extracts after
addition of C17-ceramide (Avanti Polar Lipids, Alabaster, AL,
US) as internal standard. Ceramides were extracted by solid phase
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to free sphingosine which was derivatized with O-phtalaldehyde
(Sigma, Brøndby, Denmark) before separated on a C18 HPLC
column (Gemini 5 mm C18 110 A ˚ Column 25063.0 mm)
(Phenomenex, Allerød, Denmark) and detected as fluorescence
at 450 nm (excitation at 340 nm).
Cardiac gene expression
Gene expression was measured with real-time PCR. mRNA was
extracted using the Trizol reagent (Invitrogen, Taastrup, Denmark),
quantified spectrophotometricly, and the quality was assessed with
capillary electrophoresis (2100 bioanalyzer, Agilent Technologies).
cDNA was made with M-MULV (Roche) and real-time PCR
analyses were performed with SYBR-Green and the Light Cycler
instrument (Roche). Primer sequences for mouse ACSL1, BiP,
CHOP,CTE1, Cre,GADD34,MTP-A, MTP-B,MTP-A+MTP-B,
UCP2, and UCP3 are shown in Supplementary Table S2.
Sequences for human apoB, mouse apoB, CPT1b, DGAT, FAT/
CD36, FATP1, FATP4, GLUT4, H-FABP, hypoxanthine-guanine
phosphoribosyltransferase (HPRT), LCAD, LPL, PFK, PPARc-
coactivator-1a (PGC1a), and PPARa, have been published
previously [5,31,57,58]. The expression of the reference gene
HPRT was used to normalize the expression of target genes.
In vivo evaluation of heart function
The left ventricular function was evaluated by analysis of the
pressure-volume loops acquired by conductance catheter technique
[59]. The animals were intubated and mechanically ventilated with
2.2% isoflurane in 50% O2 and 50% room air at 100 breaths/min
and a tidal volume of 10 ml/g. Temperature was maintained at
37uC by a rectal temperature-controlled heating pad and a heating
lamp. An intravenous line was established through the left jugular
vein and usedforcontinuousinfusionofisotonicNaClataninfusion
rate of 0.05 ml?g
21?h
21 throughout the protocol. The infusion of
NaCl was discontinued for 1–2 min, and the ventilator was stopped
at end expiration for 2–3 s before every measurement. The chest
was entered via an anterior thoracotomy, and a 1.4-F four-electrode
conductance catheter for mice (SPR-839; Millar Instruments,
Houston, TX) was inserted into the left ventricle through the apex
and positioned along the cardiac longitudinal axis. Pressure-volume
loops were acquired with a signal-conditioning box (MPCU-200;
Millar Instruments) using a 20-kHz excitation frequency and
sampling rate of 1,000 Hz. The parallel conductance was estimated
by intra venous injection of a 5 mL bolus of 30% hypertonic saline
over approximately 0.5 s. The volume signal was calibrated by
measuring the specific conductance of blood from each mouse by
the cylinder method as previously described [60]. Maximal and
minimal LV volumes and pressures during the cardiac cycle were
used as end diastolic volume (EDV) and end systolic volume (ESV)
and as end systolic pressure (ESP) and end diastolic pressure (EDP)
respectively.
MTP activity
MTP activity was assessed as previously described [5,61]. Briefly,
tissue biopsies of ,50 mg were homogenised and the microsomal
protein fraction was isolated by ultracentrifugation. Triglyceride
transfer activity in the microsomal protein fraction was measured as
transfer of
14C-trioleate-labeled lipid from donor vesicles to acceptor
vesicle that contained only unlabeled triglycerides.
Insulin stimulated glucose uptake in vivo
Fed mice were anesthetized with a mixture of fentanyl:droper-
idol:midazolam (0.02:1.38:0.14 mg/ml, 0.2 ml/10 g body
weight), and a mixture of 0.005 IU insulin, 1.6 mCi of 2-deoxy-
[
3H]glucose and 1.0 mCi of [
14C]sucrose/10 g body weight in
saline with 0.1% BSA was administered in the a vein.
[
14C]Sucrose was used to calculate extracellular space. After
25 minutes blood was drawn in pre-cooled Na2EDTA tubes and
heart, soleus muscle and the epididymal fat pad were isolated and
rinsed carefully in ice-cold isotonic saline and snap-frozen in liquid
nitrogen. Uptake of 2-deoxy-[
3H]glucose in heart, soleus muscle,
and epididymal fat was detected in perchloric acid extracts after
corrected for label in the extracellular space as determined by the
[
14C] counts for sucrose.
Statistics
Two-group comparison was performed with Student’s t-test or
non-parametric Mann-Whitney test when appropriate. P,0.05
was considered statistically significant. The effect of MTP-
genotype on cardiac triglycerides was calculated with two-way
ANOVA.
Supporting Information
Figure S1 MTP-A and MTP-B expression in the obese
mouse heart. Cardiac mRNA expression was quantified with
real-time PCR in male fat-fed C57Bl/6 (n=11) and and their lean
controls (n=6). Values are after 12 months of diet. Open bars:
chow-fed C57Bl/6 mice, closed bars: fat-fed C57Bl/6 mice. Values
are mean6SEM. The p values for two-group comparisons are: *
P,0.05, *** P,0.005 compared to chow-fed controls.
Found at: doi:10.1371/journal.pone.0005300.s001 (0.13 MB TIF)
Figure S2 Effect of prolonged fat-feeding on basic
metabolic parameters in male C57Bl/6 and C57Bl/6-
apoB-Tg mice. The effect of fat-feeding on A) bodyweight in
C57Bl/6 mice, B) bodyweight in C57Bl/6-apoB-Tg mice, C)
plasma glucose in C57Bl/6 and C57Bl/6-apoB-Tg mice, D)
plasma insulin in C57Bl/6 and C57Bl/6-apoB-Tg mice, E) plasma
leptin in C57Bl/6 and C57Bl/6-apoB-Tg mice. Values are after
11 months of diet and in overnight fasted mice. Open bars: chow-fed
C57Bl/6 mice (n=7), closed bars: fat-fed C57Bl/6 mice (n=7),
hatched bars: chow-fed C57Bl/6-apoB-Tg mice (n=11), squared bars:
fat-fed C57Bl/6-apoB-Tg mice (n=7). Values are mean6SEM.
The p values for two-group comparisons are indicated by: ***
P,0.005 compared to chow-fed controls.
Found at: doi:10.1371/journal.pone.0005300.s002 (0.22 MB TIF)
Table S1 Heart function in fat-fed C57Bl/6 and C57Bl/
6-apoB-Tg mice. vData are from male mice chow- or fat-fed for
11 months. Values are mean6SEM, * P,0.05; {P,0.005
compared to lean controls. EDV indicates end-diastolic volume;
ESV, end-systolic volume; ESP, end systolic pressure; EDP, end
diastolic pressure; t, isovolumic relaxation time; EDVPR, end
diastolic volume pressure relationship. P,0.05 is considered
significant.
Found at: doi:10.1371/journal.pone.0005300.s003 (0.03 MB
DOC)
Table S2 Primers used for real-time PCR.
Found at: doi:10.1371/journal.pone.0005300.s004 (0.04 MB
DOC)
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